Bafna Pharmaceuticals Limited
BSE: BAFNAPHARM
BSE
102.51
0.39 (0.38%)
Prev Close
102.12
Open Price
106.73
Volume
2,453
Today Low / High
102.5 / 107.22
52 WK Low / High
5.25 / 184
Range
97 - 108
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 102.51, reflecting a change of 0.39 (0.3819%). The expected target range on the BSE is 97 - 108. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
No data available
Bafna Pharmaceuticals Limited Graph
Bafna Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Bafna Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 102.51, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 102.51 | 103.54 | 93.18 - 113.89 |
| 104.56 | 83.65 - 125.47 | ||
| 105.59 | 73.91 - 137.26 | ||
| Bearish Scenario | 102.51 | 101.48 | 91.34 - 111.63 |
| 100.46 | 80.37 - 120.55 | ||
| 99.43 | 69.60 - 129.27 |
Overview of Bafna Pharmaceuticals Limited
ISIN
INE878I01022
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
1,467
Market Cap
242,500,731
Last Dividend
0
Official Website
IPO Date
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Stock Dividend of BAFNAPHARM
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2013-09-19 | September 19, 13 | 0.6 | 0.06 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | 115.35 Cr | 97.79 Cr | 17.56 Cr | 0.1522 | 1.52 Cr | 0.00 Cr | 10.39 Cr | 11.34 Cr | 4.79 | 15.73 Cr | 0.0983 |
| 2022-03-31 | 85.14 Cr | 71.42 Cr | 13.72 Cr | 0.1610 | 1.47 Cr | 0.00 Cr | 6.50 Cr | 5.22 Cr | 2.21 | 11.99 Cr | 0.0613 |
| 2021-03-31 | 71.22 Cr | 62.23 Cr | 8.98 Cr | 0.1261 | 1.36 Cr | 0.00 Cr | 5.85 Cr | 5.83 Cr | 2.46 | 10.33 Cr | 0.0818 |
| 2020-03-31 | 42.47 Cr | 40.54 Cr | 1.93 Cr | 0.0454 | 1.01 Cr | 0.00 Cr | -1.98 Cr | -1.88 Cr | -7.94 | 1.28 Cr | -0.0442 |
| 2019-03-31 | 43.63 Cr | 47.14 Cr | -3.52 Cr | -0.0806 | 0.75 Cr | 0.00 Cr | -16.43 Cr | -19.88 Cr | -8.40 | -12.96 Cr | -0.4557 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | 7.81 Cr | 129.58 Cr | 54.91 Cr | 73.4546 Cr | 22.92 Cr | 15.11 Cr | 23.18 Cr | 40.23 Cr | 0.04 Cr | 0.00 Cr | 0.00 Cr | 46.4763 Cr |
| 2022-03-31 | 0.17 Cr | 90.14 Cr | 27.33 Cr | 61.9637 Cr | 11.06 Cr | 10.89 Cr | 20.82 Cr | 38.85 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 22.0127 Cr |
| 2021-03-31 | 1.80 Cr | 86.47 Cr | 29.69 Cr | 56.7711 Cr | 13.00 Cr | 11.20 Cr | 25.95 Cr | 36.80 Cr | 0.89 Cr | 0.00 Cr | 0.00 Cr | 24.3087 Cr |
| 2020-03-31 | 8.48 Cr | 71.06 Cr | 20.12 Cr | 50.9455 Cr | 0.00 Cr | -8.48 Cr | 13.43 Cr | 35.18 Cr | 2.51 Cr | 0.00 Cr | 0.00 Cr | 17.0979 Cr |
| 2019-03-31 | 2.71 Cr | 119.47 Cr | 100.62 Cr | 19.0582 Cr | 46.23 Cr | 43.51 Cr | 9.28 Cr | 37.02 Cr | 1.25 Cr | 0.00 Cr | 0.00 Cr | 70.8209 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | 3.2948 Cr | -7.5223 Cr | 11.8645 Cr | -4.9239 Cr | 7.6370 Cr | 7.6370 Cr | -8.2187 Cr | 11.3380 Cr | 0.0000 Cr | 0.0000 Cr | -1.9391 Cr |
| 2022-03-31 | 9.6550 Cr | -6.5591 Cr | -4.7266 Cr | 2.1138 Cr | -1.6307 Cr | -1.6307 Cr | -7.5412 Cr | 5.2163 Cr | 0.0000 Cr | 0.0000 Cr | -4.8372 Cr |
| 2021-03-31 | -13.6580 Cr | -5.3849 Cr | 12.3684 Cr | -19.7527 Cr | -6.6745 Cr | -6.6745 Cr | -6.0947 Cr | 5.8267 Cr | 0.0000 Cr | 0.0000 Cr | -4.0309 Cr |
| 2020-03-31 | -34.3241 Cr | 32.7354 Cr | 7.3668 Cr | -35.7529 Cr | 5.7781 Cr | 5.7781 Cr | -1.4288 Cr | -1.8780 Cr | 0.0000 Cr | 0.0000 Cr | -2.1292 Cr |
| 2019-03-31 | -3.7965 Cr | 15.2449 Cr | -11.6861 Cr | -4.1296 Cr | -0.2377 Cr | -0.2377 Cr | -0.3331 Cr | -19.8803 Cr | 0.0000 Cr | 0.0000 Cr | 1.3919 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | 40.68 Cr | 34.88 Cr | 5.79 Cr | 0.1420 | 2.76 Cr | 2.48 Cr | 1.05 | 4.00 Cr | 0.0611 |
| 2023-06-30 | 41.95 Cr | 32.07 Cr | 9.88 Cr | 0.2350 | 5.08 Cr | 6.35 Cr | 2.68 | 6.30 Cr | 0.1514 |
| 2023-03-31 | 42.24 Cr | 33.94 Cr | 8.30 Cr | 0.1970 | 6.10 Cr | 5.37 Cr | 2.27 | 7.62 Cr | 0.1272 |
| 2022-12-31 | 34.22 Cr | 29.83 Cr | 4.39 Cr | 0.1280 | 2.15 Cr | 2.99 Cr | 1.27 | 3.55 Cr | 0.0875 |
| 2022-09-30 | 21.96 Cr | 18.65 Cr | 3.31 Cr | 0.1510 | 1.42 Cr | 1.61 Cr | 0.68 | 2.54 Cr | 0.0733 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | 7.86 Cr | 0.00 Cr | 7.86 Cr | 39.99 Cr | 29.36 Cr | 90.95 Cr | 40.89 Cr | 134.87 Cr | 51.34 Cr |
| 2023-03-31 | 7.81 Cr | 0.00 Cr | 7.81 Cr | 55.47 Cr | 23.18 Cr | 87.31 Cr | 40.23 Cr | 129.58 Cr | 54.91 Cr |
| 2022-09-30 | 3.55 Cr | 0.00 Cr | 3.55 Cr | 21.03 Cr | 21.58 Cr | 63.39 Cr | 42.84 Cr | 106.23 Cr | 40.39 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| No quarterly financial cash flow statement data available. | |||||||||
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2019-08-26 | August 26, 19 | 1:10 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,751.50 | ₹4,202,338,920,000.00 | ₹2,683,738.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹5,640.00 | ₹1,497,245,160,000.00 | ₹531,900.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,254.80 | ₹1,101,570,786,000.00 | ₹202,237.00 |
| Mankind Pharma Limited | MANKIND | ₹2,581.60 | ₹1,065,112,707,232.00 | ₹489,407.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,163.60 | ₹969,410,310,072.00 | ₹2,787,901.00 |
| Lupin Limited | LUPIN | ₹1,937.20 | ₹884,457,718,000.00 | ₹1,443,063.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹831.55 | ₹836,730,556,500.00 | ₹4,090,344.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,171.60 | ₹680,467,623,200.00 | ₹769,589.00 |
| Alkem Laboratories Limited | ALKEM | ₹4,953.30 | ₹592,241,314,500.00 | ₹45,830.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,342.40 | ₹378,809,171,200.00 | ₹613,037.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,404.40 | ₹356,301,897,600.00 | ₹63,964.00 |
| Laurus Labs Limited | LAURUSLABS | ₹628.05 | ₹338,677,846,650.00 | ₹1,963,259.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,694.60 | ₹336,587,875,200.00 | ₹96,774.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,168.10 | ₹297,357,376,500.00 | ₹124,155.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,646.30 | ₹256,291,045,100.00 | ₹104,543.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,413.80 | ₹229,712,810,200.00 | ₹309,368.00 |
| Piramal Enterprises Limited | PEL | ₹995.10 | ₹224,373,157,800.00 | ₹440,877.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,746.00 | ₹218,650,000,000.00 | ₹31,887.00 |
| Eris Lifesciences Limited | ERIS | ₹1,383.00 | ₹188,266,407,000.00 | ₹41,650.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹849.90 | ₹167,058,893,700.00 | ₹300,134.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹12,821.00 | ₹164,492,147,900.00 | ₹33,908.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,967.10 | ₹149,522,615,070.00 | ₹127,499.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹827.60 | ₹148,231,436,000.00 | ₹299,818.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹918.95 | ₹146,371,274,950.00 | ₹252,814.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹467.50 | ₹113,365,945,000.00 | ₹1,134,180.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,218.00 | ₹86,615,669,200.00 | ₹2,232.00 |
| FDC Limited | FDC | ₹430.45 | ₹70,081,564,500.00 | ₹58,398.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹733.60 | ₹66,489,557,232.00 | ₹336,064.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹668.50 | ₹65,373,216,650.00 | ₹88,055.00 |
| Strides Pharma Science Limited | STAR | ₹653.00 | ₹60,182,243,100.00 | ₹289,176.00 |
| Hikal Limited | HIKAL | ₹431.60 | ₹53,216,711,600.00 | ₹794,158.00 |
| Innova Captab Limited | INNOVACAP | ₹913.20 | ₹52,257,806,076.00 | ₹59,550.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹149.93 | ₹48,655,583,460.00 | ₹540,168.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹613.95 | ₹43,225,640,910.00 | ₹15,117.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹775.95 | ₹39,355,485,645.00 | ₹55,962.00 |
| Sequent Scientific Limited | SEQUENT | ₹147.34 | ₹36,879,496,680.00 | ₹955,155.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,201.80 | ₹36,415,570,200.00 | ₹6,105.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹343.65 | ₹34,460,534,700.00 | ₹25,634.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹357.45 | ₹32,624,461,500.00 | ₹108,626.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹52.36 | ₹28,690,871,440.00 | ₹2,998,041.00 |
| Suven Life Sciences Limited | SUVEN | ₹126.32 | ₹27,547,107,680.00 | ₹168,622.00 |
| Alembic Limited | ALEMBICLTD | ₹103.97 | ₹26,697,624,436.00 | ₹491,826.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹523.60 | ₹25,160,550,800.00 | ₹47,862.00 |
| Windlas Biotech Limited | WINDLAS | ₹1,084.10 | ₹22,786,697,900.00 | ₹176,971.00 |
Key Executives
No executive data available.
FAQs about Bafna Pharmaceuticals Limited
What is the current market price of the stock?
The current price is ₹102.51.
What is the 52-week price range?
The range is ₹5.25-184.0.
What is the market capitalization of the company?
The market capitalization is ₹24.25 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 27.45.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Bafna Pharmaceuticals Limited (ISIN: INE878I01022) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹24.25 crores and an average daily volume of 1,467 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.